Innovent Biologics 

$52.64
5
-$1.65-3.04% Thursday 12:04

Statistics

Day High
50.51
Day Low
50.51
52W High
54.29
52W Low
37.54
Volume
5
Avg. Volume
96
Mkt Cap
94.17B
P/E Ratio
193.89
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25AugExpected
Q1 2021
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.08
-0.02
0.04
0.1
Expected EPS
0.0691746
Actual EPS
0.103026

Financials

6.15%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.84BRevenue
113.5MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IVBIY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

INNOVENT BIOLGCS UNSP/ADR
Show more...
CEO
Dr. De-Chao Yu Ph.D.
Country
United States
ISIN
US45783L1017

Listings

0 Comments

Share your thoughts

FAQ

What is Innovent Biologics stock price today?
The current price of IVBIY is $52.64 USD — it has decreased by -3.04% in the past 24 hours. Watch Innovent Biologics stock price performance more closely on the chart.
What is Innovent Biologics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Innovent Biologics stocks are traded under the ticker IVBIY.
Is Innovent Biologics stock price growing?
IVBIY stock has risen by +0% compared to the previous week, the month change is a +22.88% rise, over the last year Innovent Biologics has showed a +10.08% increase.
What is Innovent Biologics market cap?
Today Innovent Biologics has the market capitalization of 94.17B
When is the next Innovent Biologics earnings date?
Innovent Biologics is going to release the next earnings report on March 31, 2027.
What were Innovent Biologics earnings last quarter?
IVBIY earnings for the last quarter are 0.1 USD per share, whereas the estimation was 0.07 USD resulting in a +48.94% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Innovent Biologics revenue for the last year?
Innovent Biologics revenue for the last year amounts to 1.84B USD.
What is Innovent Biologics net income for the last year?
IVBIY net income for the last year is 113.5M USD.
In which sector is Innovent Biologics located?
Innovent Biologics operates in the Other sector.
When did Innovent Biologics complete a stock split?
Innovent Biologics has not had any recent stock splits.
Where is Innovent Biologics headquartered?
Innovent Biologics is headquartered in Suzhou, United States.